OXALIPLATIN ANTI-RESISTANCE AGENT
Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil
Cetuximab plus capecitabine and oxaliplatin is an active salvage therapy for oxaliplatin-resistant or refractory colorectal cancer